Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.3.4 updates the page version from v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:15.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a centralized Locations section with Georgia and Ohio sites. Removed the separate Georgia Locations and Ohio Locations subsections and updated the page revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T22:19:28.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:27:12.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed the generic government funding/operating status notice from the page. This change does not modify the study details, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:22.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the study page; core details and status appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T21:20:49.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a new label 'Last Update Posted (Estimated)' while removing 'Last Update Posted'. This is a minor metadata wording change and does not affect core content, pricing, stock, or time-sensitive information.
    Difference
    0.0%
    Check dated 2025-10-13T09:33:18.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.